At-home sleep lab provider Wesper raises $9.6M

Steven Loeb · November 21, 2022 · Short URL: https://vator.tv/n/5587

The platform can measure inconsistent breathing throughout the night

I have sleep apnea, and when I had to get my diagnosis it involved going to a sleep lab two times: once to determine if I had sleep apnea in the first place, and then again to determine the right levels for the CPAP machine (this was a number of years ago, back when machines weren't yet dynamic and able to adjust themselves throughout the night).

Let's just say being forced to sleep in a strange place with wires hooked up to me wasn't exactly the most conducive way for me to get good sleep; I slept maybe three hours, at best. I wish I had had the ability to do the test from home, where I was most comfortable.

That is what Wesper, an FDA-cleared home sleep lab, allows for: the company uses wireless biometric sensors and algorithms that allow for an at-home medical diagnosis with professional services and ongoing measurement before, during, and after treatment.

On Monday, the company announced$9.6 million Series A round that included participation from Valor Equity Partners, Breyer Capital, Spark Capital, as well as angel investors from what it calls "leading health-tech firms."

Founded in 2017, the New York City-based Wesper allows people to test themselves in their home environment, measuring longitudinally sleep position, snoring, oxygen desaturation, apnea events, breathing quality, and pulse rate. 

All the patient has to do is stick patches to their stomach and then pair the patches to the Wesper app via bluetooth; when they wake up they will have a full report about their sleep, which they can then share with Wesper sleep specialists and physicians. The patient will then be connected with a sleep expert who will evaluate their condition and formulate a personalized treatment plan, including lifestyle and medical interventions to improve their sleep.

Wesper is not a medical device, and isn't able to detect apneas or hypopneas, but it can detect inconsistent breathing by using clinically-validated respiratory measurements to identify periods of inconsistent breathing throughout the night. That allows it to generate insights about the quality of a person's breathing, amount of time snoring, sleeping positions, heart rate, sleep time, sleep efficiency, and sleep staging. The company also provides other environmental measurements, such as patch temperature and ambient noise. 

In regards to its accuracy, the company says it has a 95.6% correlation to a sleep lab. 

Wesper says it will use the new funding to partnerships with sleep centers, dental clinics and coaches to bring its solution to more patients across the United States. The company has already on-boarded medical institutions and is set to expand its presence in the sleep clinic space, including expanding its medical advisor network. 

"Wesper is at the forefront of revolutionizing the sleep industry through superior access to biometric data and an increased focus on patient experience, working to ensure that every patient who suffers from sleep problems gets the care they deserve," Amir Reuveny, Founder and CEO of Wesper, said in a statement.

(Image source: wesper.co)